Topic: continuous glucose monitor
Biolinq tacked on an extra $4.75 million to its series A total to fund development of its coin-sized sensor patch for monitoring glucose levels.
Former Medtronic Diabetes chief medical officer Francine Kaufman has joined continuous glucose monitor developer Senseonics as its new CMO.
Glooko’s mobile app is now free for any person with diabetes, with the company ditching subscription fees for unsponsored users.
Senseonics expanded its CGM distribution deal with Roche Diabetes Care to 17 additional countries, including Brazil, Russia, India and China.
Eli Lilly expanded its work with Evidation Health in developing digital biomarkers derived from smartphones, wearable sensors and voice data.
Tandem Diabetes Care launched a new predictive feature for automatically pausing insulin delivery as a free update for its CGM-enabled insulin pumps.
Senseonics’ long-term CGM is now available in clinics across the U.S. and has secured its first commercial payer.
A comparison of three continuous glucose monitoring devices found Senseonics’ recently approved Eversense implant was significantly more accurate.
Medtronic rolled out an updated meal-logging app for its iPro2 glucose-monitoring device.
The FDA cleared DreaMed’s decision support software for managing Type 1 diabetes in patients that use insulin pumps and continuous glucose monitoring.